Lenalidomide and Combination Chemotherapy (DA-EPOCH-R) in Treating Patients With MYC-Associated B-Cell Lymphomas
University of Chicago
University of Chicago
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Universität des Saarlandes
National Institutes of Health Clinical Center (CC)
Hoffmann-La Roche
Hoffmann-La Roche
University of Nebraska
University of Nebraska
Genentech, Inc.
Weill Medical College of Cornell University
Hoffmann-La Roche
SCRI Development Innovations, LLC
Seagen Inc.
Universität des Saarlandes
Universität des Saarlandes
German High-Grade Non-Hodgkin's Lymphoma Study Group
SWOG Cancer Research Network
Hoffmann-La Roche
M.D. Anderson Cancer Center
CTI BioPharma
Hoffmann-La Roche
M.D. Anderson Cancer Center
Weill Medical College of Cornell University
Teva Branded Pharmaceutical Products R&D, Inc.
Hoffmann-La Roche
University of Southern California
Genentech, Inc.
Ohio State University Comprehensive Cancer Center
Hoffmann-La Roche
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia
Fundación Leucemia y Linfoma, Spain
Hoffmann-La Roche
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
SWOG Cancer Research Network
Northwestern University
Swiss Cancer Institute
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Auxilio Mutuo Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
St. Jude Children's Research Hospital